Literature DB >> 9427529

Regulation of the expression of follistatin in rat hepatocytes.

Y Q Zhang1, M Kanzaki, H Shibata, I Kojima.   

Abstract

To elucidate the regulation of follistatin production in the liver, we studied changes in steady-state follistatin mRNA levels in cultured rat hepatocytes. Activin A stimulated follistatin mRNA levels in a time- and concentration-dependent manner. The stimulatory effect of activin A on follistatin mRNA was significant at 2 h, maximal at 6 h and declined thereafter. Incubating the cells with EGF increased follistatin mRNA levels at 48 h and later. The EGF-induced increase in follistatin mRNA was markedly inhibited by exogenous follistatin in the culture medium, which blocks the action of activin A synthesized in hepatocytes, suggesting that endogenous activin A at least partly mediated the effect of EGF. We also examined the effects of transforming growth factor-beta (TGF-beta), glucagon and alpha-adrenergic agonist, phenylephrine, on follistatin mRNA levels. TGF-beta increased the follistatin mRNA to levels similar to those caused by activin A. Phenylephrine and glucagon also increased follistatin mRNA levels but the effects were transient and weaker than those caused by activin A. Finally, follistatin mRNA levels were markedly increased in remnant liver 3 h after 70% hepatectomy. The mRNA remained elevated for up to 72 h. These results indicate that the expression of mRNA for follistatin is positively controlled by activin A, TGF-beta and other hormones or neurotransmitters. The stimulatory effect of EGF on follistatin mRNA is mediated by activin A released from hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427529     DOI: 10.1016/s0167-4781(97)00085-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Expression changes of activin A in the development of hepatic fibrosis.

Authors:  X Huang; D G Li; Z R Wang; H S Wei; J L Cheng; Y T Zhan; X Zhou; Q F Xu; X Li; H M Lu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression.

Authors:  N A Shackel; P H McGuinness; C A Abbott; M D Gorrell; G W McCaughan
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

3.  Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.

Authors:  E Gazzerro; V Gangji; E Canalis
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

Review 4.  Hepatokines as a Molecular Transducer of Exercise.

Authors:  Dae Yun Seo; Se Hwan Park; Jubert Marquez; Hyo-Bum Kwak; Tae Nyun Kim; Jun Hyun Bae; Jin-Ho Koh; Jin Han
Journal:  J Clin Med       Date:  2021-01-20       Impact factor: 4.241

5.  Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism.

Authors:  Fen-Yu Tseng; Yen-Ting Chen; Yu-Chao Chi; Pei-Lung Chen; Wei-Shiung Yang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

6.  Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes.

Authors:  Tang Cam Phung Pham; Kirstine Nyvold Bojsen-Møller; Sten Madsbad; Jørgen Frank Pind Wojtaszewski; Erik Arne Richter; Lykke Sylow
Journal:  Int J Obes (Lond)       Date:  2020-09-01       Impact factor: 5.095

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.